User profiles for N. M. Anstey
 | Nicholas AnsteyMenzies School of Health Research Verified email at menzies.edu.au Cited by 31768 |
[HTML][HTML] Vivax malaria: neglected and not benign
Plasmodium vivax threatens almost 40% of the world’s population, resulting in 132-391 million
clinical infections each year. Most of these cases originate from South East Asia and the …
clinical infections each year. Most of these cases originate from South East Asia and the …
Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature
…, D Lo, S Selva-Nayagam, NM Anstey… - Clinical Infectious …, 2000 - academic.oup.com
In a prospective study of melioidosis in northern Australia, 252 cases were found over 10
years. Of these, 46% were bacteremic, and 49 (19%) patients died. Despite administration of …
years. Of these, 46% were bacteremic, and 49 (19%) patients died. Despite administration of …
Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection
Over the past decade or more, the prevalence of traditional risk factors for atherosclerotic
cardiovascular diseases has been increasing in the major populous countries of the …
cardiovascular diseases has been increasing in the major populous countries of the …
Common West African HLA antigens are associated with protection from severe malaria
A large case-control study of malaria in West African children shows that a human leucocyte
class I antigen (HLA-Bw53) and an HLA class II haplotype (DRB1 * 1302–DQB1 * 0501), …
class I antigen (HLA-Bw53) and an HLA class II haplotype (DRB1 * 1302–DQB1 * 0501), …
[HTML][HTML] Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia
E Tjitra, NM Anstey, P Sugiarto, N Warikar… - PLoS …, 2008 - journals.plos.org
Background Multidrug-resistant Plasmodium vivax (Pv) is widespread in eastern Indonesia,
and emerging elsewhere in Asia-Pacific and South America, but is generally regarded as a …
and emerging elsewhere in Asia-Pacific and South America, but is generally regarded as a …
The pathophysiology of vivax malaria
Long considered a benign infection, Plasmodium vivax is now recognized as a cause of
severe and fatal malaria, despite its low parasite biomass, the increased deformability of vivax-…
severe and fatal malaria, despite its low parasite biomass, the increased deformability of vivax-…
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
… Price, Ric N a,b,c ; Douglas, Nicholas M a,c ; Anstey, Nicholas M a,b … 15•• Tjitra E,
Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe …
Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe …
Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression.
NM Anstey, JB Weinberg, MY Hassanali… - The Journal of …, 1996 - rupress.org
… Anstey is currently at the Menzies School of Health 1kesearch, Darwin, NT, Australia; Donald
L. Granger is at the Division of Infectious Diseases, University of Utah School of Medicine, …
L. Granger is at the Division of Infectious Diseases, University of Utah School of Medicine, …
Artemisinin combination therapy for vivax malaria
Early parasitological diagnosis and treatment with artemisinin-based combination therapies
(ACTs) are key components of worldwide malaria elimination programmes. In general, use …
(ACTs) are key components of worldwide malaria elimination programmes. In general, use …
The relationship between age and the manifestations of and mortality associated with severe malaria
Background. The reported case-fatality rate associated with severe malaria varies widely.
Whether age is an independent risk factor is uncertain. Methods. In a large, multicenter …
Whether age is an independent risk factor is uncertain. Methods. In a large, multicenter …